Cardiovascular Revascularization Medicine
Volume 11, Issue 1 , Pages 29-33 , January 2010

Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design

  • Gianluca Rigatelli

      Affiliations

    • Cardiovascular Diagnosis and Interventions Unit, Rovigo General Hospital, Verona, Italy
    • Corresponding Author InformationCorresponding author. Via Mozart, 9, 37045 Legnago, Verona, Italy. Tel.: +3903471912016; fax: +39044220164.
    • ,
  • Paolo Cardaioli

      Affiliations

    • Cardiovascular Diagnosis and Interventions Unit, Rovigo General Hospital, Verona, Italy
    • ,
  • Fabio Dell'Avvocata

      Affiliations

    • Cardiovascular Diagnosis and Interventions Unit, Rovigo General Hospital, Verona, Italy
    • ,
  • Massimo Giordan

      Affiliations

    • Cardiovascular Diagnosis and Interventions Unit, Rovigo General Hospital, Verona, Italy
    • ,
  • Gabriele Braggion

      Affiliations

    • Cardiovascular Diagnosis and Interventions Unit, Rovigo General Hospital, Verona, Italy
    • ,
  • Mauro Chinaglia

      Affiliations

    • Department of Neurosciences, Division of Neurology, Trascranial Doppler Service, Rovigo General Hospital, Verona, Italy
    • ,
  • Loris Roncon

      Affiliations

    • Cardiovascular Diagnosis and Interventions Unit, Rovigo General Hospital, Verona, Italy

Received 16 February 2008 ,Revised 27 March 2008 ,Accepted 15 April 2008.

References 

  1. Schwerzmann M, Wiher S, Nedeltchev K. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004;2:1399–1401
  2. Morandi E, Anzola GP, Casilli F, Onorato E. Migraine: traditional or “innovative” treatment? A preliminary case-control study. Pediatr Cardiol. 2005;[Electronic publication ahead of print]
  3. Reisman M, Christofferson RD, Jesurum J. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005;45:493–495
  4. SPREAD—Stroke Prevention and Educational Awareness Diffusion: Stroke Italian Guidelines. 4th ed.. 2005;www.spread.it
  5. Sloan MA, Alexandrov AV, Tegeler CH. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004;62:1468–1481
  6. Lang RM, Bierig M, Devereux RB, et al. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108
  7. Olesen J. The International classification of headache disorders. 2nd ed.. Cephalalgia. 2004;24:1–160
  8. Stewart WF, Lipton RB, Whyte J, Dowson A, kolodner K, Liberman JN, et al. An international study to assess reliability of the migraine disability assessment (MIDAS) score. Neurology. 1999;53:988
  9. Zanchetta M, Onorato E, Rigatelli G, et al. Intracardiac echocardiography-guided transcatheter closure of secundum atrial septal defect: a new efficient device selection method. J Am Coll Cardiol. 2003;5(42):1677–1682
  10. Rigatelli G, Hijazi ZM. Intracardiac echocardiography in cardiovascular catheter-based interventions: different devices for different purposes. J Invasive Cardiol. 2006;18:225–233
  11. Olivares-Reyes A, Chan S, Lazar EJ, Bandlamudi K, Narla V, Ong K. Atrial septal aneurysm: a new classification in two hundred five adults. J Am Soc Echocardiogr. 1997;10:644–656
  12. Zanchetta M, Rigatelli G, Pedon L, Onorato E, Carrozza A, Maiolino P. Catheter closure of perforated secundum atrial septal defect under intracardiac echocardiographic guidance using a single Amplatzer device: feasibility of a new method. J Invasive Cardiol. 2005;17:262–265
  13. Boutin C, Musewe NN, Smallhorn JF, et al. Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device. Circulation. 1993;88:621–627
  14. Rigatelli G. Headache and heart defects: closing a hole to free the mind?. Headache. 2007;47(6):930–932
  15. Rigatelli G, Braggion G, Aggio S, Chinaglia M, Cardaioli P. Primary patent foramen ovale closure to relieve severe migraine. Ann Intern Med. 2006;144:458–459
  16. Giardini A, Donti A, Formigari R. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J. 2006;151:922.e1–922.e5
  17. Rigatelli G, Cardaioli P, Braggion G, Giordan M, Fabio D, Aggio S, et al. Resolution of migraine by transcatheter patent foramen ovale closure with Premere occlusion system in a preliminary series of patients with previous cerebral ischemia. Catheter Cardiovasc Interv. 2007;70:429–433
  18. Anzola GP, Morandi E, Casilli F, Onorato E. Does transcatheter closure of patent foramen ovale really “shut the door?” A prospective study with transcranial Doppler. Stroke. 2004;35:2140–2144
  19. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004;43:302–309
  20. Rigatelli G, Cardaioli P, Braggion G, Giordan M, Aggio S, Roncon L. ICE-guided patent foramen ovale (PFO) closure with latest-generation devices: the ideal strategy for PFO-related migraine?. J Cardiovasc Med (Hagerstown). 2007;8:633–635

☆ None of the authors have conflict of interest in the subject matter of the research, excepted Dr G Rigatelli who is proctor, consultant, and lecturer for St Jude Medical Corp for 3000 euros per year.

PII: S1553-8389(08)00206-6

doi: 10.1016/j.carrev.2008.04.002

Cardiovascular Revascularization Medicine
Volume 11, Issue 1 , Pages 29-33 , January 2010

Article Tools

* Image Usage & Resolution